A single brain-derived neurotrophic factor infusion into the dorsomedial prefrontal cortex attenuates cocaine self-administration-induced phosphorylation of synapsin in the nucleus accumbens during early withdrawal

International Journal of Neuropsychopharmacology

Volumn 18, Issue 1, 2015, Pages

  Sun, Wei Lun ^a   Eisenstein, Sarah A ^b   Zelek Molik, Agnieszka ^c   McGinty, Jacqueline F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Cocaine self administration; Immunoblotting; Nucleus accumbens; Phosphatase; Synapsin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; PHOSPHOPROTEIN PHOSPHATASE 2A; SYNAPSIN; CENTRAL NERVOUS SYSTEM AGENTS; DOPAMINE UPTAKE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DORSOMEDIAL PREFRONTAL CORTEX; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SYNAPSE VESICLE; WITHDRAWAL SYNDROME; ANIMAL; COCAINE-RELATED DISORDERS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM AGENTS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; MALE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPSINS;

EID: 84935015706     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu049     Document Type: Article

References (50)

1. Baldelli P, Fassio A, Valtorta F, Benfenati F (2007) Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci 27:13520-13531.
2. Benfenati F, Bahler M, Jahn R, Greengard P (1989) Interactions of synapsin I with small synaptic vesicles: distinct sites in synapsin I bind to vesicle phospholipids and vesicle proteins. J Cell Biol 108:1863-1872.
3. Benfenati F, Neyroz P, Bahler M, Masotti L, Greengard P (1990) Time-resolved fluorescence study of the neuron-specific phosphoprotein synapsin I. Evidence for phosphorylationdependent conformational changes. J Biol Chem 265:12584-12595.
4. Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr, Miller SW, McGinty JF (2007) A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 26:757-766.
5. Berglind WJ, Whitfield TW Jr, LaLumiere RT, Kalivas PW, McGinty JF (2009) A single intra-PFC infusion of BDNF prevents cocaineinduced alterations in extracellular glutamate within the nucleus accumbens. J Neurosci 29:3715-3719.
6. Bogen IL, Boulland JL, Mariussen E, Wright MS, Fonnum F, Kao HT, Walaas SI (2006) Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. J Neurochem 96:1458-1466.
7. Bogen IL, Haug KH, Roberg B, Fonnum F, Walaas SI (2009) The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals. Neurochem Int 55:13-21.
8. Chi P, Greengard P, Ryan TA (2001) Synapsin dispersion and reclustering during synaptic activity. Nature Neurosci 4:1187-1193.
9. Chi P, Greengard P, Ryan TA (2003) Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 38:69-78.
10. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatr 156:11-18.
11. DeRemer MF, Saeli RJ, Edelman AM (1992) Ca(2+)-calmodulindependent protein kinases Ia and Ib from rat brain I. Identification, purification, and structural comparisons. J Biol Chem 267:13460-13465.
12. Edwards S, Graham DL, Bachtell RK, Self DW (2007) Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration. Eur J Neurosci 25:2201-2213.
13. Fremeau RT, Jr., Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH (2004) Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304:1815-1819.
14. Gitler D, Xu Y, Kao HT, Lin D, Lim S, Feng J, Greengard P, Augustine GJ (2004a) Molecular determinants of synapsin targeting to presynaptic terminals. J Neurosci 24:3711-3720.
15. Gitler D, Takagishi Y, Feng J, Ren Y, Rodriguiz RM, Wetsel WC, Greengard P, Augustine GJ (2004b) Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci 24:11368-11380.
16. Gitler D, Cheng Q, Greengard P, Augustine GJ (2008) Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles. J Neurosci 28:10835-10843.
17. Go BS, McGinty JF (2013) Synaptic activity mediates ability of BDNF-TrkB signaling to suppress cocaine-seeking in rats. Soc Neurosci NeurOnline Planner 820.15.
18. Goldstein RZ, Volkow ND (2011) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652-669.
19. Haubensak W, Narz F, Heumann R, Lessmann V (1998) BDNF-GFP containing secretory granules are localized in the vicinity of synaptic junctions of cultured cortical neurons. J Cell Sci 111 (Pt 11):1483-1493.
20. Hearing MC, Miller SW, See RE, McGinty JF. Relapse to cocaine seeking increases activity-regulated gene expression differentially in the prefrontal cortex of abstinent rats. Psychopharmacology 198:77-91, 2008.
21. Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P (1999) Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354:269-279.
22. Hilfiker S, Benfenati F, Doussau F, Nairn AC, Czernik AJ, Augustine GJ, Greengard P (2005) Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:2658-2669.
23. Hosaka M, Hammer RE, Sudhof TC (1999) A phospho-switch controls the dynamic association of synapsins with synaptic vesicles. Neuron 24:377-387.
24. Huttner WB, Schiebler W, Greengard P, De Camilli P (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96:1374-1388.
25. Jovanovic JN, Benfenati F, Siow YL, Sihra TS, Sanghera JS, Pelech SL, Greengard P, Czernik AJ (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A 93:3679-3683.
26. Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS (2000) Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 3:323-329.
27. Jovanovic JN, Sihra TS, Nairn AC, Hemmings HC Jr, Greengard P, Czernik AJ (2001) Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals. J Neurosci 21:7944-7953.
28. Jovanovic JN, Thomas P, Kittler JT, Smart TG, Moss SJ (2004) Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability. J Neurosci 24:522-530.
29. Kile BM, Guillot TS, Venton BJ, Wetsel WC, Augustine GJ, Wightman RM (2010) Synapsins differentially control dopamine and serotonin release. J Neurosci 30:9762-9770.
30. Koob GF, Caine SB, Parsons L, Markou A, Weiss F (1997) Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 57:513-521.
31. Lutgen V, Kong L, Kau KS, Madayag A, Mantsch JR, Baker DA (2014) Time course of cocaine-induced behavioral and neurochemical plasticity. Addict Biol 19:529-538.
32. McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537.
33. McGinty JF, Whitfield TW Jr, Berglind WJ (2010) Brain-derived neurotrophic factor and cocaine addiction. Brain Res 1314:183-193.
34. Miguens M, Del Olmo N, Higuera-Matas A, Torres I, Garcia-Lecumberri G, Ambrosio E (2008) Glutamate and aspartate levels in the nucleus accumbens during cocaine self-administration and extinction: a time course microdialysis study. Psychopharmacol 196:303-313.
35. Padmanabhan S, Prasad BM (2009) Sustained depolarization decreases calcium/calmodulin-dependent protein kinase II activity and gene expression in dopamine neurons. Neuroscience 163:277-285.
36. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. Burlington, MA: Elsevier Academic.
37. Picciotto MR, Zoli M, Bertuzzi G, Nairn AC (1995) Immunochemical localization of calcium/calmodulin-dependent protein kinase I. Synapse 20:75-84.
38. Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, Hammer RE, Malenka RC, Sudhof TC (1995) Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375:488-493.
39. Sihra TS, Wang JK, Gorelick FS, Greengard P (1989) Translocation of synapsin I in response to depolarization of isolated nerve terminals. Proc Natl Acad Sci U S A 86:8108-8112.
40. Sun W, Rebec GV (2006) Repeated cocaine self-administration alters processing of cocaine-related information in rat prefrontal cortex. J Neurosci 26:8004-8008.
41. Sun WL, Zhou L, Quinones-Jenab V, Jenab S (2009) Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats. Brain Res Bull 80:377-381.
42. Sun WL, Zelek-Molik A, McGinty JF (2013) Short and long access to cocaine self-administration activates tyrosine phosphatase STEP and attenuates GluN expression but differentially regulates GluA expression in the prefrontal cortex. Psychopharmacology (Berl) 229:603-613.
43. Suska A, Lee BR, Huang YH, Dong Y, Schluter OM (2013) Selective presynaptic enhancement of the prefrontal cortex to nucleus accumbens pathway by cocaine. Proc Natl Acad Sci USA 110:713-718.
44. Tyler WJ, Pozzo-Miller L (2001) BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zone of hippocampal excitatory synapses. J Neurosci 21:4249-4258.
45. Vara H, Onofri F, Benfenati F, Sassoe-Pognetto M, Giustetto M (2009) ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I. Proc NAtl Acad Sci USA 106:9872-9877.
46. Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P, Augustine GJ, Wightman RM (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206-3209.
47. Wang JQ, McGinty JF (1997) Glutamate-dopamine interactions mediate the effects of psychostimulant drugs. Addict Biol 4:141-150.
48. White FJ, Kalivas PW (2001) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153.
49. Whitfield TW Jr, Shi X, Sun WL, McGinty JF (2011) The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signalregulated protein kinase mitogen-activated protein kinase dependent. J Neurosci 31:834-842.
50. Wydra K, Golembiowska K, Zaniewska M, Kaminska K, Ferraro L, Fuxe K, Filip M (2013) Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats. Addict Biol 18:307-324.